Treatable trait guided asthma management: biomarker changes and responder analysis
Aim: In a feasibility study, treatable trait (TT) guided asthma management showed clinically relevant improvements in asthma control (ACQ), quality of life (AQLQ), health status (SGRQ) and FEV1 (Fingleton et al, TSANZ ASM 2023). Changes in two type-2 (T2) biomarkers, blood eosinophils and FeNO, and associations between baseline characteristics and treatment response are described here.
Methods: Ten week two-centre open-label intervention study of patients with asthma receiving medication titrated to presence of two TTs: T2 inflammation and airflow obstruction. Participants had ACQ >1 and ≥1 exacerbation in last 12 months. Linear regression estimates changes in continuous response variables in relation to predictors.
Results: Airflow obstruction was present in 18/30 (60%) participants. Although TT intervention was associated with reduction of type-2 inflammation (Figure); change in ACQ, AQLQ, or SGRQ was not associated with baseline FEV1/FVC, log FeNO, blood eosinophils or composite T2 biomarker status. Final FEV1% predicted, adjusted for baseline, was associated with baseline airflow obstruction. Change in FEV1 predicted per unit increase FEV1/FVC ratio (95% CI), -1.69% (-2.26 to -1.13), P<0.001.
Puedes leer el artículo completo aquí: https://erj.ersjournals.com/content/62/suppl_67/PA3604
Authors: James Fingleton, Rob Mclachlan, Jenny Sparks, Richard Beasley, Alvar Agusti, Peter G Gibson, Ian Pavord, Jo Hardy, Mark Weatherall, Allie Eathorne, Vanessa M Mcdonald
European Respiratory Journal 2023 62: PA3604; DOI: 10.1183/13993003.congress-2023.PA3604
Noticias relacionadas
Addressing the Global Challenges of COPD and Asthma: A Shared Vision From the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)
Analysis of the global challenges of COPD and asthma and the shared vision of GOLD and GINA to improve diagnosis, access to inhaled therapies and patient outcomes worldwide.
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD
Joint GOLD/GLI statement on spirometry to define airflow obstruction and confirm COPD diagnosis, aiming to harmonize criteria and improve global practice.
Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care
Review on climate change and respiratory health, focusing on chronic respiratory diseases and implications for primary and specialist care.
Artículos
Asthma
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 768973·James Fingleton, Rob Mclachlan, Jenny Sparks, Richard Beasley, Alvar Agusti, Peter G Gibson, Ian Pavord, Jo Hardy, Mark Weatherall, Allie Eathorne, Vanessa Mcdonal -Treatable trait guided asthma management: biomarker changes and responder analysis
- 768973·Xander Bertels et Al.- Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration
- 769799·Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría GOLD en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en artículo original.